Is Cresco Labs stock a good cannabis company to buy?

June 28, 2023 07:36 AM PDT | By Invezz
 Is Cresco Labs stock a good cannabis company to buy?
Image source: Invezz

Cannabis stocks have lagged the broader market this year. The Global X Cannabis ETF (POTX) stock has dropped by almost 405 this year while the S&P 500 and Nasdaq 100 indices have jumped by double-digits this year. Cresco Labs (NASDAQ: CRLBF) stock price has dropped by 15% this year and by more than 41% in the past 12 months.

Modest improvements

Cresco Labs is a Canadian company that has huge operations in the United States. The company operates retail stores in key states where people can buy assorted cannabis products. In 2020, it launched Sunnyside, an e-commerce platform where people can shop capsules, vapes, concentrates, edibles, flowers, and other products.

Sunnyside is having strong growth. In the most recent quarter, its cumulative sales jumped to over $1 billion for the first time on record. 

Cresco Labs revenue in the quarter came in at $194 million, a 3% decline from the previous quarter. It attributed this decline to Illinois, where growth has eased in the past few months. The company ended the quarter with $90 million in cash, It is also working to improve its spending in a bid to reduce its cash outflows.

Cresco Labs has been improving its operations. In 2022, it revenue jumped to over $824 million while its total loss narrowed by over $100 million to $212 million. Analysts now believe that the company will break even in 2025.

Therefore, while the company is losing money, it is doing better than other cannabis companies like Cronos Group and Canopy Growth. I believe that Sunnyside’s e-commerce platform will help to support this growth. 

The biggest risk for Cresco Labs is the acquisition of Columbia Care, a company whose growth has been sluggish. Columbia’s revenue came in at $125 million in the last quarter. It lost more than $36 million during the quarter. 

Cresco Labs stock price forecast

Cresco Labs chart by TradingView

The daily chart shows that the Cresco Labs share price has moved sideways since April. It has remained slightly above the year-to-date low of $1.38. The stock has also remained below the important resistance point at $1.95, the highest point on May 25th. As a result, it is hovering near the 25-day and 50-day moving averages.

Cresco Labs stock price remains sharply below the all-time high while the MACD is moving below the neutral point. Therefore, the outlook of the stock is neutral and I expect it to remain in this range for a while.

A break below the support at $1.38 will signal that there are more sellers in the market. If this happens, the next level to watch will be at $1. On the flip side, a move above the resistance point at $1.95 will signal that there are still more buyers left.

The post Is Cresco Labs stock a good cannabis company to buy? appeared first on Invezz.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media LLC (Kalkine Media, we or us) and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures/music displayed/used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it, as necessary.


Sponsored Articles


Investing Ideas

Previous Next